|
Re: Wonder what the big investors think currently
|
3
|
Resverlogix Corp.
|
Dec 03, 2023 12:14PM
|
|
July 4th USA
|
3
|
Resverlogix Corp.
|
Jul 04, 2023 12:24PM
|
|
Zenith AGM Agenda
|
3
|
Zenith Epigenetics
|
Oct 10, 2019 10:03AM
|
|
Re: Story time with tada
|
3
|
Resverlogix Corp.
|
Feb 16, 2018 01:37PM
|
|
Re: Phase 3 Status with a European Regulatory Authority
|
3
|
Resverlogix Corp.
|
Jun 22, 2015 08:45AM
|
|
Re: Liquidity
|
3
|
Zenith Epigenetics
|
Aug 03, 2019 02:55PM
|
|
Re: August News - Thank You Don!
|
3
|
Resverlogix Corp.
|
Aug 27, 2015 02:26PM
|
|
AGM Content
|
3
|
Zenith Epigenetics
|
Oct 08, 2021 10:44AM
|
|
Re: Zenith funding???
|
3
|
Zenith Epigenetics
|
Jun 17, 2019 01:57PM
|
|
Re: The wail of the nervous retail shareholder....
|
3
|
Resverlogix Corp.
|
Jun 24, 2015 08:24AM
|
|
Idea for Zenith
|
3
|
Zenith Epigenetics
|
Jul 13, 2021 07:39PM
|
|
AGM
|
3
|
Zenith Epigenetics
|
Sep 08, 2021 10:56AM
|
|
Re: A lesson on futility analyses from the CETP inhibitors
|
3
|
Resverlogix Corp.
|
May 10, 2017 03:26PM
|
|
Re: Added due to participants
|
3
|
Resverlogix Corp.
|
Jun 20, 2017 12:23PM
|
|
Re: The latest numbers for Alberta.
|
3
|
Resverlogix Corp.
|
Sep 20, 2021 12:56PM
|
|
My Current Wish List
|
3
|
Resverlogix Corp.
|
Aug 27, 2018 03:44PM
|
|
Re: Zenith poster from AACR EORTC meeting and Annual General/Special meeting date
|
3
|
Resverlogix Corp.
|
Nov 13, 2015 09:49AM
|
|
Re: BetonMace Phase 111 Trial opinions...
|
3
|
Resverlogix Corp.
|
Jun 05, 2015 09:05AM
|
|
Middle Eastern $
|
3
|
Resverlogix Corp.
|
Sep 01, 2023 12:06PM
|
|
Re: Lilly to Discontinue Development of Evacetrapib
|
3
|
Resverlogix Corp.
|
Nov 17, 2015 04:31PM
|
